Clinical Action Messages
COCA provides subscribers information on current health issues and emerging threats. The Clinical Action email messages are alerts, advisories, and updates of important clinical information and resources related to specific events. Some Clinical Action email messages may ask that clinicians take immediate action while others reemphasize why clinicians should continue to follow CDC guidance in their practice.
2018 Clinical Action Messages
- November 26: Outbreak Alert Update: Potential Life-Threatening Vitamin K-Dependent Antagonist Coagulopathy Associated With Synthetic Cannabinoids Use
- August 7: CDC Urges Follow-up Evaluation of Babies Born to Women with Zika Virus Infection during Pregnancy
- April 23: Outbreak Alert Update: Potential Life-Threatening Vitamin K-Dependent Antagonist Coagulopathy Associated With Synthetic Cannabinoids Use
- April 5: Outbreak Alert: Potential Life-Threatening Vitamin K-Dependent Antagonist Coagulopathy Associated With Synthetic Cannabinoids Use
Page last reviewed: March 7, 2022
Content source: Centers for Disease Control and Prevention